{"data":{"id":"us-me/22-m.r.s.-2672","jurisdiction":"us-me","citation":"22 M.R.S. §2672","heading":"Availability of investigational drug, biological product or device by manufacturer","body":"A manufacturer of an investigational drug, biological product or device may make available the investigational drug, biological product or device to an eligible patient.\n1.  Compensation.  A manufacturer may provide an investigational drug, biological product or device to an eligible patient with or without receiving compensation.\n2.  Costs.  A manufacturer may require an eligible patient to pay the costs of manufacturing the dosage of an investigational drug, a biological product or a device dispensed to that eligible patient.","path":["TITLE 22: HEALTH AND WELFARE","SUBTITLE 2: HEALTH","PART 5: FOODS AND DRUGS","CHAPTER 602-A: ACCESS TO INVESTIGATIONAL TREATMENTS FOR TERMINALLY ILL PATIENTS"],"source_url":"https://legislature.maine.gov/statutes/22/title22sec2672.html","current_through":"January 1, 2026","vintage":"","retrieved_at":"2026-09-04T15:12:31Z","sha256":"bbbe3d1defdca10e045990ff7833cbe84d6a6ce8167e4e9b83a926d582458ef2","source_id":"us-me","stale":false,"prev":"us-me/22-m.r.s.-2671","next":"us-me/22-m.r.s.-2673"},"notice":"GroundRules: Original legal text. Not legal advice."}